319 related articles for article (PubMed ID: 23791655)
1. Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients.
Ferreira F; Esteves S; Almeida LS; Gaspar A; da Costa CD; Janeiro P; Bandeira A; Martins E; Teles EL; Garcia P; Azevedo L; Vilarinho L
Gene; 2013 Sep; 527(1):366-70. PubMed ID: 23791655
[TBL] [Abstract][Full Text] [Related]
2. FMO3 allelic variants in Sicilian and Sardinian populations: trimethylaminuria and absence of fish-like body odor.
D'Angelo R; Esposito T; Calabrò M; Rinaldi C; Robledo R; Varriale B; Sidoti A
Gene; 2013 Feb; 515(2):410-5. PubMed ID: 23266626
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing.
Guo Y; Hwang LD; Li J; Eades J; Yu CW; Mansfield C; Burdick-Will A; Chang X; Chen Y; Duke FF; Zhang J; Fakharzadeh S; Fennessey P; Keating BJ; Jiang H; Hakonarson H; Reed DR; Preti G
BMC Med Genet; 2017 Feb; 18(1):11. PubMed ID: 28196478
[TBL] [Abstract][Full Text] [Related]
4. Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
Shimizu M; Kobayashi Y; Hayashi S; Aoki Y; Yamazaki H
Mol Genet Metab; 2012 Nov; 107(3):330-4. PubMed ID: 22819296
[TBL] [Abstract][Full Text] [Related]
5. Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.
Motika MS; Zhang J; Zheng X; Riedler K; Cashman JR
Mol Genet Metab; 2009 Jun; 97(2):128-35. PubMed ID: 19321370
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects identified by phenotyping for trimethylaminuria and found in a database of genome resources.
Shimizu M; Koibuchi N; Mizugaki A; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
Drug Metab Pharmacokinet; 2021 Jun; 38():100387. PubMed ID: 33831674
[TBL] [Abstract][Full Text] [Related]
7. Novel variants and haplotypes of human
Shimizu M; Yoda H; Igarashi N; Makino M; Tokuyama E; Yamazaki H
Xenobiotica; 2019 Oct; 49(10):1244-1250. PubMed ID: 30351217
[TBL] [Abstract][Full Text] [Related]
8. Trimethylaminuria and a human FMO3 mutation database.
Hernandez D; Addou S; Lee D; Orengo C; Shephard EA; Phillips IR
Hum Mutat; 2003 Sep; 22(3):209-13. PubMed ID: 12938085
[TBL] [Abstract][Full Text] [Related]
9. Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.
Cashman JR; Bi YA; Lin J; Youil R; Knight M; Forrest S; Treacy E
Chem Res Toxicol; 1997 Aug; 10(8):837-41. PubMed ID: 9282831
[TBL] [Abstract][Full Text] [Related]
10. Transient trimethylaminuria related to menstruation.
Shimizu M; Cashman JR; Yamazaki H
BMC Med Genet; 2007 Jan; 8():2. PubMed ID: 17257434
[TBL] [Abstract][Full Text] [Related]
11. Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort.
Akerman BR; Lemass H; Chow LM; Lambert DM; Greenberg C; Bibeau C; Mamer OA; Treacy EP
Mol Genet Metab; 1999 Sep; 68(1):24-31. PubMed ID: 10479479
[TBL] [Abstract][Full Text] [Related]
12. Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
Yamazaki H; Fujita H; Gunji T; Zhang J; Kamataki T; Cashman JR; Shimizu M
Mol Genet Metab; 2007 Jan; 90(1):58-63. PubMed ID: 16996766
[TBL] [Abstract][Full Text] [Related]
13. A spectrum of molecular variation in a cohort of Italian families with trimethylaminuria: identification of three novel mutations of the FM03 gene.
Teresa E; Lonardo F; Fiumara A; Lombardi C; Russo P; Zuppi C; Scarano G; Musumeci S; Gianfrancesco F
Mol Genet Metab; 2006 Jun; 88(2):192-5. PubMed ID: 16600650
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism of the flavin-containing monooxygenase 3 (FMO3) associated with trimethylaminuria (fish odor syndrome): observations from Japanese patients.
Yamazaki H; Shimizu M
Curr Drug Metab; 2007 Jun; 8(5):487-91. PubMed ID: 17584019
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and phenotypic assessment of trimethylaminuria, and its treatment with riboflavin:
Bouchemal N; Ouss L; Brassier A; Barbier V; Gobin S; Hubert L; de Lonlay P; Le Moyec L
Orphanet J Rare Dis; 2019 Sep; 14(1):222. PubMed ID: 31533761
[TBL] [Abstract][Full Text] [Related]
16. Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.
Shimizu M; Allerston CK; Shephard EA; Yamazaki H; Phillips IR
Br J Clin Pharmacol; 2014 May; 77(5):839-51. PubMed ID: 24028545
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants of flavin-containing monooxygenase 3 (FMO3) derived from Japanese subjects with the trimethylaminuria phenotype and whole-genome sequence data from a large Japanese database.
Shimizu M; Yoda H; Nakakuki K; Saso A; Saito I; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
Drug Metab Pharmacokinet; 2019 Oct; 34(5):334-339. PubMed ID: 31401033
[TBL] [Abstract][Full Text] [Related]
18. Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.
Zhou J; Shephard EA
Mutat Res; 2006 Jun; 612(3):165-171. PubMed ID: 16481213
[TBL] [Abstract][Full Text] [Related]
19. Adaptive Modelling of Mutated FMO3 Enzyme Could Unveil Unexplored Scenarios Linking Variant Haplotypes to TMAU Phenotypes.
Alibrandi S; Nicita F; Donato L; Scimone C; Rinaldi C; D'Angelo R; Sidoti A
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834137
[TBL] [Abstract][Full Text] [Related]
20. Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria.
Zhang J; Tran Q; Lattard V; Cashman JR
Pharmacogenetics; 2003 Aug; 13(8):495-500. PubMed ID: 12893987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
